Skip to main content

Table 3 Comparison of treatment details

From: Budesonide inhalation suspension versus methylprednisolone for treatment of moderate bronchial asthma attacks

 

mPSL group

BIS group

p

(n = 20)

(n = 20)

Duration of wheezing (days)

4.5 ± 1.3

4.0 ± 1.6

n.s.

Duration of steroid use (days)

4.9 ± 2.2

5.1 ± 1.2

n.s.

Hospitalization (days)

7.7 ± 2.3

6.9 ± 1.9

n.s.

Total intermittent procaterol inhalations during hospitalization (number)

16.6 ± 5.4

10.5 ± 3.5

<0.001

ECP at discharge (mg/L)

33.7 ± 25.8 (n = 7)

30.7 ± 31.1 (n = 13)

n.s.

  1. mPSL, methylprednisolone; BIS, budesonide inhalation suspension; ECP, eosinophil cationic protein; n.s., not significant.